(0.30%) 5 146.75 points
(0.30%) 38 555 points
(0.41%) 17 920 points
(-0.80%) $83.18
(2.08%) $1.963
(-0.29%) $2 340.50
(0.95%) $27.51
(0.50%) $926.70
(-0.26%) $0.932
(-0.23%) $11.00
(-0.34%) $0.798
(0.59%) $92.42
-3.60% INR 2 546.75
Live Chart Being Loaded With Signals
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, and marbofloxacin for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications...
Stats | |
---|---|
Šios dienos apimtis | 5 902.00 |
Vidutinė apimtis | 10 415.00 |
Rinkos kapitalizacija | 15.73B |
EPS | INR0 ( 2024-02-12 ) |
Kita pelno data | ( INR0 ) 2024-05-12 |
Last Dividend | INR1.750 ( 2023-08-17 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 41.38 |
ATR14 | INR3.86 (0.15%) |
Tūris Koreliacija
NGL Fine-Chem Limited Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
NGL Fine-Chem Limited Koreliacija - Valiuta/Žaliavos
NGL Fine-Chem Limited Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR2.78B |
Bruto pelnas: | INR1.38B (49.54 %) |
EPS: | INR33.18 |
FY | 2022 |
Pajamos: | INR2.78B |
Bruto pelnas: | INR1.38B (49.54 %) |
EPS: | INR33.18 |
FY | 2022 |
Pajamos: | INR3.13B |
Bruto pelnas: | INR1.66B (53.01 %) |
EPS: | INR80.77 |
FY | 2021 |
Pajamos: | INR2.55B |
Bruto pelnas: | INR1.53B (59.87 %) |
EPS: | INR91.81 |
Financial Reports:
No articles found.
NGL Fine-Chem Limited Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR1.750 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.750 | 2023-08-17 |
Last Dividend | INR1.750 | 2023-08-17 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | INR1.750 | -- |
Avg. Dividend % Per Year | 0.04% | -- |
Score | 1.26 | -- |
Div. Sustainability Score | 4.71 | |
Div.Growth Potential Score | 3.51 | |
Div. Directional Score | 4.11 | -- |
Year | Amount | Yield |
---|---|---|
2023 | INR1.750 | 0.11% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RICOAUTO.NS | Dividend Junior | 2023-09-22 | Annually | 22 | 0.54% | |
L&TFH.NS | Dividend Junior | 2023-07-21 | Annually | 12 | 0.77% | |
FOCUS.NS | Dividend Junior | 2023-08-18 | Sporadic | 6 | 1.23% | |
APCOTEXIND.NS | Dividend Junior | 2023-06-12 | Annually | 22 | 0.99% | |
TATAPOWER.NS | Dividend Junior | 2023-06-07 | Annually | 29 | 0.85% | |
NRBBEARING.NS | Dividend Junior | 2023-09-22 | Annually | 23 | 1.22% | |
INDOTHAI.NS | Dividend Junior | 2023-09-15 | Annually | 10 | 0.58% | |
COCHINSHIP.NS | Dividend Knight | 2023-09-21 | Semi-Annually | 7 | 5.03% | |
SBC.NS | Dividend Junior | 2023-09-18 | Insufficient data to determine frequency | 2 | 0.11% | |
MAHLOG.NS | Dividend Junior | 2023-07-13 | Annually | 7 | 0.30% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.120 | 1.500 | 7.60 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.164 | 1.500 | 9.29 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 36.81 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 36.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 36.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.494 | 1.000 | 5.10 | 5.10 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.140 | 1.000 | 9.21 | 9.21 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.71 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.95 | 1.000 | 5.76 | 0 | [1 - 100] |
returnOnEquityTTM | 0.164 | 2.50 | 9.54 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 36.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.0662 | 1.500 | 8.34 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 36.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.729 | 1.500 | -8.19 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0717 | 1.000 | -0.706 | 0 | [0.1 - 0.5] |
Total Score | 3.51 |
NGL Fine-Chem Limited
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, and marbofloxacin for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications. The company also provides various intermediate products; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.